Foresight Diagnostics (a Natera company) Alternatives & Competitors
12 companies similar to Foresight Diagnostics (a Natera company) — Precision medicine company dedicated to improving the lives of cancer patients t...
Companies similar to Foresight Diagnostics (a Natera company)
Predicine
Advancing precision medicine through next-generation liquid biopsy oncology platform
CellMax Life
Liquid biopsy company focused on cancer screening with a proprietary platform for detectin...
Adaptive Biotechnologies Corp.
Every immune system has a story to tell; the key is knowing how to listen.
Personal Genome Diagnostics
Leading the way in patient-specific cancer genome analysis with groundbreaking technologie...
Rival Readout
Competing with Foresight Diagnostics (a Natera company)? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Singlera Genomics Incorporated
Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA).
Rarity Bioscience
Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation det...
Lucence
Overcoming cancer through earlier detection
HaploX Global
HaploX specializes in genetic testing solutions, gene sequencing, liquid biopsy, bioinform...
Personalis, Inc.
Ultrasensitive ctDNA testing
Geneseeq Technology Inc.
Cancer: a word, not a sentence!
About Foresight Diagnostics (a Natera company)
Foresight Diagnostics, now a part of Natera, is a precision medicine company committed to enhancing cancer patient care through advanced detection methodologies. Founded in 2020 by four Stanford University visionaries—physicians and scientists—the company is noted for its high-performing circulating tumor DNA (ctDNA) a...
diagnostic test development for cancer, ultra-sensitive MRD platform, clinical program execution, bioinformatics support
biopharmaceutical companies, academic researchers, oncologists
Precision Medicine, Cancer Detection, Circulating Tumor DNA, Minimal Residual Disease, Liquid Biopsy, Phased Variant Detection, Bioinformatics, CLIA Laboratory, Oncology, Patient Management, Proprietary Technology, Assay Development, Stanford-founded, Pharmaceutical Partnerships, Cancer Diagnostics
B2B, D2C, B2D
Service Fee, Usage Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Foresight Diagnostics (a Natera company): 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Foresight Diagnostics (a Natera company) on 4 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.